

2. Mem Inst Oswaldo Cruz. 2018 Jan;113(1):62-65. doi: 10.1590/0074-02760170071.

Detection of occult hepatitis B in serum and oral fluid samples.

Portilho MM(1), Nabuco LC(2), Villela-Nogueira CA(2), Brandão-Mello CE(3),
Pilotto JH(4)(5), Flores GL(1), Lewis-Ximenez LL(1), Lampe E(1), Villar LM(1).

Author information: 
(1)Fundação Oswaldo Cruz-Fiocruz, Instituto Oswaldo Cruz, Laboratório de
Hepatites Virais, Rio de Janeiro, RJ, Brasil.
(2)Universidade Federal do Rio de Janeiro, Hospital Universitário Clementino
Fraga Filho, Rio de Janeiro, RJ, Brasil.
(3)Universidade Federal do Estado do Rio de Janeiro, Hospital Universitário
Gaffrée e Guinle, Rio de Janeiro, RJ, Brasil.
(4)Hospital Geral de Nova Iguaçu, Nova Iguaçu, RJ, Brasil.
(5)Fundação Oswaldo Cruz-Fiocruz, Instituto Oswaldo Cruz, Laboratório de AIDS e
Imunologia Molecular, Rio de Janeiro, RJ, Brasil.

In occult hepatitis B infection (OBI), hepatitis B virus DNA (HBV DNA) can be
detected in serum samples; however, oral fluid collection for detection of HBV
DNA has not yet been explored, despite the availability of collection devices.
Serum and oral fluid samples from 45 hepatitis B core antibody
(anti-HBc)-positive patients were collected for the amplification of the HBV
polymerase gene. HBV DNA was detected in five serum and four oral fluid samples
(the detection limit for oral fluid was 1.656 log IU/mL in paired serum). In
conclusion, simple methodologies of sample collection and in-house polymerase
chain reaction (PCR) allowed detection of HBV DNA, and these could be used to
improve the diagnosis of OBI, especially in locations with limited resources.

DOI: 10.1590/0074-02760170071 
PMCID: PMC5719542
PMID: 29211108  [Indexed for MEDLINE]
